MarketPulse — Real-Time Financial News & Market Analysis

Latest News

15,577 articles
Tue, Mar 10
BenzingaBenzinga··Business Wire

BlackSky's Fourth Gen-3 Satellite Achieves First Light in Hours, Accelerating Intelligence Constellation

BlackSky's fourth Gen-3 satellite achieves operational first light within hours of launch, demonstrating rapid constellation deployment capabilities in growing tactical intelligence market.
BKSYBKSY.WSspace-based intelligencesatellite imagery
BenzingaBenzinga··Prnewswire

IceCure Medical to Release 2025 Results March 17, Signaling Year-End Performance Review

IceCure Medical will report 2025 full-year results March 17, 2026, before market open, with a conference call at 11:00 a.m. EDT.
ICCMfinancial resultsearnings announcement
BenzingaBenzinga··Namrata Sen

Ackman's Pershing Square Eyes $5-10B Dual NYSE IPO After Failed 2024 Attempt

Bill Ackman files for combined IPOs of Pershing Square hedge fund and new Pershing Square USA fund, targeting $5-10 billion raise at $50 per share.
METAAMZNCMGHHHUNVGYIPOBill Ackman
The Motley FoolThe Motley Fool··Jennifer Saibil

Berkshire's Dividend Jackpot: $1.3B From Coca-Cola and AmEx in 2025

Berkshire Hathaway harvested $1.3B in dividends from Coca-Cola and American Express in 2025, earning 65% and 44% yields-on-cost from nearly 40-year holdings.
AXPAAPLBRK.ABRK.BKO+1dividend incomedividend growth
BenzingaBenzinga··Akanksha Bakshi

Amentum Lands $112M EU Nuclear Cleanup Contract Across Four Nations

Amentum wins $112M EU nuclear decommissioning contract spanning Italy, Germany, Belgium, Netherlands with two-year initial term plus potential six-year extensions.
RWJAMTMIJSSLYVvaluationtechnical analysis
The Motley FoolThe Motley Fool··Adam Levy

Gates Foundation Concentrates $38B Portfolio in Three 'Moat' Stocks, Shuns Tech

Gates Foundation invests 60% of $38B portfolio in Berkshire Hathaway, Waste Management, and Canadian National Railway—reflecting Buffett's value investing philosophy and eschewing technology.
BRK.ABRK.BWMCNIvalue investingBerkshire Hathaway
BenzingaBenzinga··Na

Catheter Precision Completes Full Acquisition of Fly Flyte, Enters Aviation Sector

$VTAK completes acquisition of remaining 80.02% stake in Fly Flyte, achieving 100% ownership of FAA-certified regional aviation operator with active revenue operations.
VTAKCRTDDacquisitionFAA certification
GlobeNewswire Inc.GlobeNewswire Inc.··Ibn

Fusion Energy Player Targets 1GW Deployment by 2028 at 6.25¢/kWh

Kepler Fusion Technologies targets 1GW power capacity by 2028 using aneutronic fusion, pricing at 6.25¢/kWh with projected 80%+ EBITDA margins in Texas markets.
RNWFclean energyfusion energy
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Cerence, Vivoka Partner to Bring Voice AI to Industrial Markets

Cerence and Vivoka partner to deliver embedded voice AI for industrial logistics and field services, claiming up to 70% error reduction in challenging environments.
CRNCstrategic partnershiplogistics
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Gauzy Seeks Buyers for French Units as Nasdaq-Listed Firm Battles Financial Headwinds

Gauzy seeks buyers for French subsidiaries in court-supervised reorganization, appoints three board members amid financial challenges and Nasdaq compliance pressures.
GAUZboard appointmentsfinancial distress
GlobeNewswire Inc.GlobeNewswire Inc.··Unknown

Pimly Launches Product Intelligence Tool on Salesforce AgentExchange Platform

Pimly launches Product Intelligence on Salesforce AgentExchange, combining product data management with AI agents to prevent hallucinations and automate customer service for retailers and manufacturers.
CRMCGNXautomationAgentforce
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Protara Posts $57.4M Annual Loss as TARA-002 Bladder Cancer Data Bolsters Pipeline

Protara Therapeutics reported $57.4M full-year 2025 loss while unveiling promising 68% response rate for TARA-002 in bladder cancer trial with funding extending to 2028.
TARAfinancial resultsclinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Feiba VH Market Poised for Steady Growth Through 2035 on Rising Hemophilia Cases

Feiba VH market projected to grow through 2035 driven by rising hemophilia diagnoses, healthcare spending, and surgical procedures. North America leads; Asia-Pacific fastest-growing.
TAKAsia-Pacificmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

LGI Homes Expands Colorado Footprint with $469K Entry into Denver-Area Farmstead

LGI Homes enters Colorado's Denver market via Farmstead community in Berthoud, offering eight floor plans starting at $469,900 with $7M in amenities.
LGIHmaster-planned communitynew community
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bitcoin Depot Pivots to Fintech with ReadyBucks Platform Launch

Bitcoin Depot launches ReadyBucks, offering $500-$2,000 business advances to gig workers across nine states, expanding beyond crypto services.
BTMBTMWWfintechworking capital
BenzingaBenzinga··Lekha Gupta

Apollo Launches First U.K. Retirement Fund, Tapping Pension Market Growth

Apollo Global Management launches its first U.K. pension fund, the CG Apollo Global Diversified Credit LTAF, targeting defined contribution schemes with diversified global credit access.
APOAPOSAPOpAprivate creditApollo Global Management
The Motley FoolThe Motley Fool··David Dierking

VOO vs. RSP: Which S&P 500 Strategy Fits Your Portfolio in 2026?

VOO's tech-heavy 33% allocation outperformed in growth markets but lags as 2026 sees sector rotation. RSP's equal-weight approach offers better diversification and recent outperformance.
RSPVOOportfolio allocationS&P 500
BenzingaBenzinga··Djs Law Group

Energy Storage Firm Eos Energy Hit With Securities Lawsuit Over Production Claims

Eos Energy Enterprises ($EOSE) faces class action lawsuit alleging false statements about production capabilities and battery performance, with downtime exceeding forecasts.
EOSEsecurities fraudclass action lawsuit
BenzingaBenzinga··Prnewswire

Soligenix's SGX945 Earns UK Innovative Medicine Designation for Behçet's Disease

Soligenix's SGX945 earns UK Promising Innovative Medicine designation for Behçet's Disease, enabling early patient access with Phase 2 data showing 40% ulcer improvement.
SNGXrare diseaseBehçet's Disease
The Motley FoolThe Motley Fool··Travis Hoium

Target's Bargain Valuation Masks Deep Operational Challenges

Target trades at mid-teens P/E ratio, appearing cheap versus Walmart, but faces 13 quarters of declining sales. New CEO's $2B turnaround plan offers uncertain recovery amid consumer headwinds.
WMTTGTvaluationsame-store sales